ClinicalTrials.Veeva

Menu

The Serotonergic Transmitter System in Dementia and Affective Disorders

Rigshospitalet logo

Rigshospitalet

Status

Unknown

Conditions

Alzheimer Disease
Mood Disorders

Study type

Observational

Funder types

Other

Identifiers

NCT00192998
SERT-AD

Details and patient eligibility

About

The aim of this project is to examine the serotonergic transmitter system using functional imaging of the brain (positron emission tomography [PET]) to gain knowledge about early pathophysiological changes in Alzheimer's dementia and mood disorders.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Moderate to severe Alzheimer's disease
  • Individuals genetically predisposed to affective disorder
  • Healthy gender and age matched controls

Exclusion criteria

  • Contraindications to magnetic resonance imaging (MRI)
  • Use of psychoactive drugs
  • Past or present affective disorder
  • Other systemic diseases that may affect brain function

Trial contacts and locations

1

Loading...

Central trial contact

Steen G. Hasselbalch, MD; Vibe G. Frokjaer, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems